Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients [Phase 2]
Phase 2 trial investigating anlotinib hydrochloride capsules combined with CAPEOX in RAS and BRAF wild-type metastatic colorectal cancer; st…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy [Phase 2]
Phase 2 trial comparing Fruquintinib plus capecitabine versus capecitabine as maintenance therapy after first-line chemotherapy in metastati…
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial examining sequential Fruquintinib with Bevacizumab and FOLFIRI versus Bevacizumab plus FOLFIRI sequential Fruquintinib in meta…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer [Phase 2]
Phase 2 trial evaluating durvalumab and tremelimumab with radiation or ablation in metastatic colorectal cancer has completed and posted res…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC [Phase 2]
Phase 2 trial update investigating SBRT sequential CapeOX with Bevacizumab and Sintilimab as first-line treatment for metastatic colorectal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Dabrafenib + Trametinib + PDR001 In Colorectal Cancer [Phase 2]
Phase 2 trial investigating dabrafenib + trametinib in combination with PDR001 for metastatic colorectal cancer is in early evaluation with …
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC [Phase 1, Phase 2]
Phase Ib/II trial evaluating ONC201 plus nivolumab in metastatic colorectal cancer has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study [Phase 2]
Phase II single-arm prospective trial evaluating pemetrexed as salvage therapy in metastatic colorectal cancer after failure of standard che…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy [Phase 2]
Phase 2 trial evaluating pemetrexed plus Tarceva as salvage therapy in EGFR-overexpressed metastatic colorectal cancer after failure of stan…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Transversus Abdominis Plane Block Plus Quadratus Lumborum Block or Retrolaminar Block of Multiple Injections for Postoperative Analgesia Following Laparoscopic Colorectal Surgery [Phase 4]
A Phase 4 clinical trial update evaluating transversus abdominis plane block plus quadratus lumborum block or retrolaminar block for postope…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity [NA]
A completed clinical trial evaluating a patient-centered intervention to reduce financial toxicity in cancer patients, with results posted i…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy [Phase 2]
Phase 2 trial evaluating irinotecan hydrochloride and cetuximab with or without ramucirumab in advanced colorectal cancer after progression …
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update on combination immunotherapy for metastatic colorectal cancer showing efficacy results.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study [Phase 4]
Phase 4 clinical trial update on volatile anesthesia and perioperative outcomes in cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status [Phase 2, Phase 3]
An exploratory Phase 2/3 clinical trial evaluating combined conversion immunotherapy for liver metastases from unresectable MSS-type colorec…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Vicriviroc in combination with pembrolizumab in advanced/metastatic microsatellite-stabl…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Evaluation of the Efficacy and Safety of Single Dose Tranexamic Acid in Reducing Blood Loss During Colorectal Cancer Surgery [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of a single-dose tranexamic acid to reduce blood loss during colorectal cancer surgery ha…
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy [Phase 2]
Phase 2 trial update evaluating hepatic arterial infusion chemotherapy with Fruquintinib as third-line therapy for colorectal cancer with li…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial investigating cabozantinib in patients with refractory metastatic colorectal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study [Phase 2]
Phase 2 clinical trial update for CRC-CHAMP platform focusing on colorectal cancer prevention with chemoprevention strategies.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil [Phase 3]
Phase 3 trial evaluating irinotecan with or without panitumumab or cyclosporine in advanced/metastatic colorectal cancer refractory to fluor…
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Synergism of Immunomodulation and Tumor Ablation [Phase 2]
Phase 2 clinical trial evaluating immunomodulation combined with tumor ablation in colorectal cancer with liver metastases has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC [Phase 3]
Phase 3 trial update assessing interchangeability between TRS003 and Bevacizumab for metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer [Phase 2]
Phase 2 trial evaluating trametinib and panitumumab in RAS/RAF wild-type advanced colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer [Phase 2]
Phase 2 trial evaluating Envafolimab as neoadjuvant immunotherapy for resectable locally advanced colorectal cancer with dMMR/MSI-H status.